XML 19 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Operating expenses:    
Research and development expenses $ 694 $ 450
General and administrative expenses (Note 13a) 2,936 1,031
Operating loss (3,630) (1,481)
Financial income (expense), net (Note 13b) 351 (1,485)
Net loss (3,279) (2,966)
Addition to net loss (for EPS purpose)    
Deemed dividend with respect to the repurchase of right for future investment (292) (3)
Net loss applicable to Common stockholders (3,571) (2,969)
Other comprehensive income (loss):    
Foreign currency translation adjustments (78)
Changes in unrealized gains on marketable equity securities 26
Other comprehensive income (loss) (52)
Comprehensive loss $ (3,279) $ (3,018)
Basic and diluted net loss per share $ (0.61) $ (0.86)
Weighted average number of shares of common stock used in computing basic and diluted net loss per share 5,649,262 3,438,842